Discover how this "Bromelain Guardian" passes the torch to the next generation. From pioneering Taiwan's bromelain to international botanical drugs and U.S. strategic resources, the second-generation leaders at Challenge Bioproducts (CBC) are creating miracles in burn treatment.

Learn how Ifan Lin and Irene Lin are transforming their father, CK Lin's biotech legacy into a global force. From developing the plant-based burn treatment NexoBrid to securing FDA approval, they're writing a new chapter in Taiwan's pharmaceutical industry.

Read more: https://news.gbimonthly.com/tw/magazine/article_show.php?num=68972